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Effector memory T (Tem) cells are essential media-
tors of autoimmune disease and delayed-type hy-
persensitivity (DTH), a convenient model for two-
photon imaging of Tem cell participation in an
inflammatory response. Shortly (3 hr) after entry
into antigen-primed ear tissue, Tem cells stably at-
tached to antigen-bearing antigen-presenting cells
(APCs). After 24 hr, enlarged Tem cells were highly
motile along collagen fibers and continued to mi-
grate rapidly for 18 hr. Tem cells rely on voltage-
gated Kv1.3 potassium channels to regulate calcium
signaling. ShK-186, a specific Kv1.3 blocker, in-
hibited DTH and suppressed Tem cell enlargement
and motility in inflamed tissue but had no effect on
homing to or motility in lymph nodes of naive and
central memory T (Tcm) cells. ShK-186 effectively
treated disease in a rat model of multiple sclerosis.
These results demonstrate a requirement for Kv1.3
channels in Tem cells during an inflammatory im-
mune response in peripheral tissues. Targeting
Kv1.3 allows for effector memory responses to be
suppressed while central memory responses remain
intact.
INTRODUCTION
Costimulation-independent CCR7CD45RA effector memory
T (Tem) cells are essential mediators of numerous chronic in-
flammatory autoimmune diseases including rheumatoid arthri-
tis (RA), multiple sclerosis (MS), type I diabetes mellitus
(T1DM), and psoriasis (Beeton et al., 2006; Conrad et al.,
2007; Ellis and Krueger, 2001; Haegele et al., 2007; Kivisakk
et al., 2004; Krakauer et al., 2006; Rus et al., 2005; Wulff
et al., 2003b). Tem cells are a tissue-resident subset of602 Immunity 29, 602–614, October 17, 2008 ª2008 Elsevier Inc.memory T cells that display immediate effector function at
the site of antigen deposition (Sallusto et al., 2004). Tem cells
respond in nonlymphoid tissues, where they initiate a localized
inflammatory immune response. Upon activation, CD4+ Tem
cells give rise to T helper 1 cells (Tem effectors) that produce
interferon gamma (IFN-g), interleukin-2 (IL2), tumor necrosis
factor alpha and beta (TNF-a and TNF-b), all potent mediators
of the inflammatory response that recruit and activate macro-
phages, which, in turn, secrete TNF-a and interleukin-1 (IL1).
Together, these events inaugurate the self-propagating local-
ized inflammatory immune response that is typical of de-
layed-type hypersensitivity (DTH) and autoimmune diseases.
DTH in rats, as in humans, is characterized by tissue swelling
and infiltration in the subcutaneous layer and dermis by IFN-g-
and TNF-a-expressing Tem cells (Gaga et al., 1991; Hancock
et al., 1994).
Fluorescence microscopy and single-cell patch-clamp stud-
ies show that quiescent human peripheral blood CD4+ and
CD8+ naive, central memory T (Tcm), and Tem cells have similar
channel phenotypes expressing 300 voltage-gated Kv1.3 po-
tassium channels per cell and 10 calcium-activated KCa3.1
potassium channels per cell. Upon activation, naive and Tcm
cells upregulate KCa3.1 channels, whereas Tem cells upregulate
Kv1.3 channels when they change into Tem effectors (Wulff
et al., 2003b). In Tem cells, Kv1.3 localizes at the immune
synapse during antigen presentation and regulates the mem-
brane potential of these cells, maintaining the driving force for in-
flux of Ca2+ ions during cell activation (Beeton et al., 2005;
Chandy et al., 2004; Panyi et al., 2004; Rus et al., 2005). Genetic
silencing of Kv1.3 in human T cells leads to an expansion of Tcm
cells and a depletion of Tem cells, highlighting the functional
importance of the Kv1.3 channel in the Tem population (Hu
et al., 2007). Specific Kv1.3 inhibitors preferentially suppress cal-
cium flux, cytokine production, and proliferation in vitro of
CCR7 Tem effector cells without affecting the function of naive
and Tcm cells (Beeton et al., 2005; Beeton et al., 2006; Wulff
et al., 2003b).
Disease-associated autoreactive T cells from the blood of pa-
tients with MS, RA, or T1DM display the Tem-effector-specific
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disease-irrelevant antigens from the same patient populations
or T cells specific for autoantigens in control populations are
CCR7+Kv1.3lo naive T or Tcm cells (Beeton et al., 2006;
Rus et al., 2005; Wulff et al., 2003b). In rats, T cells at the site
of a DTH response are CD4+CCR7CD45RCKv1.3hi Tem effec-
tor cells (Beeton et al., 2006), and the T cells infiltrating the skin in
acute contact dermatitis are CD8+CCR7CD45RCKv1.3hi Tem
effector cells (Azam et al., 2007). Thus, T cells at sites of inflam-
mation in humans and in rats are Kv1.3hi Tem effectors.
The differences in K+ channel phenotype between naive, Tcm
cells, and Tem cells, together with the selective suppressive ef-
fects of Kv1.3 inhibitors on Tem cells, make Kv1.3 an attractive
therapeutic target, with potential to spare chronic autoim-
mune-disease sufferers from side effects associated with
Figure 1. Characterization of Ova-GFP T Cells
(A) Flow-cytometric analysis of the indicated cell-surface proteins on Ova-
specific GFP+ CD4+ rat T cells. The cells are CCR7 CD45RC, characteristic
of Tem cells (solid line = resting Ova-GFP+ T cells, dotted line = background
staining; gray = activated).
(B) Kv1.3 channel expression in resting (mean = 461 ± 69 Kv1.3 channels/cell,
n = 11 cells) and activated (1862 ± 208 Kv1.3 channels/cell, n = 23) GFP+ CD4+
Ova-specific rat T cells. Data were obtained by patch-clamp analysis.
(C) Kv1.3 channel expression in GFP+ Ova-specific T cells isolated from ears
undergoing DTH, 3 hr (307 ± 74 Kv1.3 channels/cell, n = 7 cells) and 24 hr
(1136 ± 162 Kv1.3 channels/cell, n = 9 cells) after challenge with Ova.broad-range immunosuppression. Specific inhibitors of Kv1.3
suppress active DTH and contact dermatitis, both caused by
skin-homing Tem cells (Azam et al., 2007; Beeton et al., 2006;
Soler et al., 2003), and have pronounced effects on adoptive ex-
perimental autoimmune encephalomyelitis (EAE), pristane-
induced arthritis, and experimental autoimmune diabetes
mellitus, common models for MS, RA, and T1DM, respectively
(Beeton et al., 2005; Beeton et al., 2006). Moreover, these inhib-
itors demonstrate good safety profiles in both rats and Rhesus
macaques (Azam et al., 2007; Beeton et al., 2006; Pereira et al.,
2007).
Here, by two-photon imaging of ear tissue during a DTH re-
sponse, we provide direct visualization of Tem cell dynamics
and resolve the in vivo implications of Kv1.3 channel block in
an antigen-challenged Tem cell population. Adoptive transfer
of in vitro-activated GFP-expressing ovalbumin-specific
CD4+CCR7CD45RC-Kv1.3hi Tem cells induces a highly repro-
ducible DTH response upon subsequent local challenge by sub-
cutaneous injection of antigen. By combining this system with
two-photon microscopy and peripheral tissue preparation for
live-cell imaging, we imaged the activation and motility of Tem
cells in inflamed tissue during a DTH reaction. In addition, we
show that ShK-186 preferentially suppresses the in vivo motility
and activation of Tem cells at the inflamed site without affecting
the motility of naive and Tcm cells in lymph nodes. Therefore, we
examined whether the selective suppression of Tem cells via
Kv1.3 blockade effectively treats chronic EAE, a model of MS,
and whether such therapy compromises the immune response
to two common and medically important infectious agents—in-
fluenza virus and Chlamydia trachomatis.
RESULTS
GFP+ Ovalbumin-Specific T Cells Display Tem Markers
and Abundant Kv1.3 Channels
Ova-specific GFP+ CD4+ rat Tem cells (Flugel et al., 1999) lack
surface expression of CCR7 and CD45RC (Figure 1A) and upon
in vitro activation upregulate Kv1.3 expression (Figure 1B and
Figure S1A, available online). These cells also upregulate
Kv1.3 channels in vivo during the DTH response (Figure 1C).
Kv1.3 numbers in GFP+ Ova-specific Tem cells were low 3 hr
after Ova challenge in the ear, indicating that these cells had
reverted to a quiescent state during the 48 hr following adop-
tive transfer. As DTH progressed, the cells reactivated in the
ear and expressed large numbers of Kv1.3 channels 24 hr after
Ova challenge. CD25 and VLA-1 were also upregulated,
whereas expression of VLA-4a (CD49d) was downregulated
and expression of CD11a and CD29 was unchanged
(Figure S1B).
Development of Adoptive DTH andPreparation of Tissue
for Imaging
Ova-specific GFP+ Tem effector cells generated by antigen-spe-
cific activation in vitro were adoptively transferred intraperitone-
ally into Lewis rats that were subsequently challenged in one ear
with ovalbumin conjugated to Texas red (Ova-TR) and in the
other ear with saline (Figure S2). Substantial increases in ear
thickness (>50% increase in thickness) were seen as early as
3 hr after antigen challenge (Figure 2A). The increase in earImmunity 29, 602–614, October 17, 2008 ª2008 Elsevier Inc. 603
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(A) DTH assessed bymeasurement of the difference in ear thickness (D ear thickness) between the Ova-TR-injected ear and the saline-injected ear and plotted as
% change at different times after antigen challenge.
(B) Hematoxylin and Eosin stain of a cross-section through an intact rat ear showing the various tissue layers, and indicating those layers removed for imaging.
The scale bar represents 50 mm.
(C) Rat ear section from an imaged preparation stained with Hematoxylin and Eosin. The scale bar represents 50 mm.thickness was maintained through the 42 hr time point. Using an
ear explant preparation, we removed the epidermis and some of
the dermis along with hair follicles (Figure 2B) that produced
image-obscuring autofluorescence. Extravascular cells were im-
aged in the remaining dermis and underlying subcutaneous tis-
sue (Figure 2C).
Motility of Tem Cells and Tem Effectors during
Development of DTH
Two-photon imaging (Figures 3A–3C and Movie S1) revealed
Ova-specific GFP+ Tem cells (green), presumptive (antigen-pre-
senting cells (APCs) that had taken up and concentrated Ova-TR
(red), and collagen structures visualized with second-harmonic
generation (blue). At the 3 hr time point after Ova-TR injection
into the ear, the majority of GFP+ Ova-specific cells were immo-
tile and usually maintained stable contact with red-labeled Ova-
TR-bearing APCs (Figure 3A and Movie S2). At the 24 hr time
point, enlarged and highly motile cells extended long membrane
projections while migrating along collagen in distinct subcutane-
ous regions and paused but did not arrest on Ova-TR-bearing
APCs (Figure 3B and Movie S3). The heterogenous localization
of Tem effector cells was confirmed histologically (data not
shown) and is consistent with previous histological studies of
DTH in rats and humans (Gaga et al., 1991; Hancock et al.,
1994). At the 42 hr time point, effectors remained enlarged and
highly motile (Figure 5D) and continued to crawl along colla-
gen-fiber bundles in the midst of Ova-TR-containing APCs
(Figure 3C and Movie S4).
At the 3 hr time point, effector cells in contact with a local APC
migrated with an average velocity of 3.9 mm/min, slower than
cells in contact with collagen (5.3 mm/min) (Figure 3D). As DTH
progressed, enlarged Tem cells migrated faster, with average
velocities at 24 hr of 7.4 mm/min when in contact with APCs
and 11.1 mm/min when in contact with collagen (Figure 3E). By
42 hr, the enlarged effectors maintained high velocities, moving
at 7.0 mm/min when making short-lived contacts with APCs and
12.0 mm/min while crawling along collagen (Figure 3F). Interest-
ingly, the size of the activated effectors correlated with their ve-604 Immunity 29, 602–614, October 17, 2008 ª2008 Elsevier Inc.locity; larger cells moved with higher average velocities than
smaller cells (Figure 3G). At the 3 hr time point, 70% of cells
were in contact with Ova-TR-bearing APCs at any given time
and, as the DTH reaction developed, the proportion of time
that effector T cells were in contact with APCs decreased pro-
gressively (Figure 3H). Contact durations at 3 hr often ex-
ceeded the length of our imaging records (30 min). Later in
the DTH reaction, interaction times became progressively
shorter, with mean durations of 7 min at 24 hr and 3 min at
42 hr (Figure 3I).
In order to confirm that cell motility and contact durations in
the ear tissue were not significantly altered by the explant imag-
ing preparation, we performed intravital imaging of adoptive DTH
in the rat paw 24 hr after antigen challenge (Figure S3 and Movie
S5). Velocities (averaging 8.5 mm/min) and the average contact
duration (7 min) of enlarged, activated Ova-specific GFP+
T cells in the rat paw were similar to those characteristics deter-
mined by imaging of ear tissue.
In addition, to examine the behavior of bystander T cells, we
imaged motility of Ova-specific GFP+ T cells during a DTH re-
sponse to an irrelevant antigen. After initiation of an active DTH
response with hen-egg lysozyme (HEL), Ova-specific Tem effec-
tor cells infiltrated the inflamed ear tissue and migrated rapidly
along collagen fibers with an average velocity of 10.4 um/min
(Figures 3J–3L; Movie S6), comparable to the velocities of anti-
gen-activated Tem cells migrating on collagen (Figures 3B and
3E). Unlike Tem cell behavior in the DTH response to cognate an-
tigen, Tem cells infiltrating the site of inflammation induced by ir-
relevant antigen failed to enlarge (Figure 3L), indicating that they
did not reactivate in vivo.
Tem Effector Cell Movement along Collagen
We further analyzed the patterns of migration of highly motile
Tem effector cells along collagen networks in inflamed tissue
(24 hr time point) as they moved along collagen fibers and inter-
acted with Ova-TR-bearing APCs (Figure 4). Effector T cells pre-
dominantly followed paths parallel to the larger collagen
bundles, (white cell tracks, Figures 4A and 4B; Movie S7).
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overall displacement from origin/distance traveled (meander in-
dex) was consistent with movement directed by structural con-
straints (Figure 4C). At junctions within the local collagen scaf-
fold, effector cells closely tracked along the collagen, often
resulting in circuitous pathways in which the overall cell displace-
ment was minimal (Figure 4D and Movie S8). Effectors were also
able to change direction by traversing from fiber to fiber at junc-
tions (red and gold tracks; Figure 4E). This pattern of directedmi-
gration of Tem effectors predominantly along collagen bundles
contrasts sharply with the apparent random-walk migration of
CCR7+ T cells in rat (cf. Figure 7D) or mouse lymph nodes (Miller
et al., 2002).
Suppression of DTH by Kv1.3 Channel Block
ShK-186, a synthetic analog of the ShK peptide isolated from the
sea anenome Stichodactyla helianthus, is modified at the N ter-
minus to increase specificity for Kv1.3 while retaining picomolar
potency (Beeton et al., 2005, 2006). ShK-186 blocked the Kv1.3
current in the Ova-specific GFP+ Tem cells in a dose-dependent
manner (Figure 5A). At concentrations that blocked the Kv1.3
channel, ShK-186 suppressed antigen-specific proliferation of
the Tem cells (Figure 5B). ShK-186 (100 mg/kg) administered
by subcutaneous injection in the scruff of the neck at the time
of Ova-TR challenge and 24 hr later (Figure S4A) reduced DTH
(smallerD ear thickness) at all time points compared to rats given
saline injections (Figure 5C). The circulating levels of ShK-186 in
injected rats (Figure S4B) were sufficient to suppress the prolif-
eration of the Tem cells. The total number of extravascular
GFP+ Tem effectors recovered from each ear was the same in
rats administered saline or ShK-186 injections (Figure 5D), indi-
cating that ShK-186 treatment did not prevent Ova-specific
GFP+ Tem effectors from entering the ear tissue. By 42 hr the
numbers of GFP+ cells in the ear had decreased in both saline-
and ShK-186-treated rats (Figure 5D).
Suppression of TemCellMotility and Activation byKv1.3
Channel Block
At all time points after Ova-TR injection into the ear, the majority
of GFP+ Ova-specific Tem cells in ShK-186-treated rats were in
contact only with the collagen matrix (Figures 6A–6C and 6G;
Movie S9) and only made intermittent contacts with Ova-
TR-bearing APCs, in contrast to saline-treated animals, in which
Tem cells maintained stable contact with APCs. At 24 and 42 hr
into the DTH reaction, the Tem cells remained small and rela-
tively immotile in ShK-186-treated rats (Figures 6B and 6C;
Movies S10 and S11). Mean velocities at 3 hr, 24 hr, and 42
hr in ShK-186-treated rats were < 2.5 mm/min (Figures 6D–
6F), in striking contrast to the rapid velocities (7–12 mm/min)
seen in saline-treated control rats at later times (Figures 3E
and 3F). Moreover, Tem cells failed to enlarge during the course
of the DTH reaction (Figure 6H). These results indicate that, al-
though Ova-specific Tem cells enter normally into inflamed tis-
sues in ShK-186-treated rats, once in the tissue the peptide
prevents the cells from becoming reactivated and immobilizes
them.
Skin-homing memory T cells involved in DTH express high
levels of b1 integrins that facilitate the migration of these cells
to a site of antigenic challenge via integrin interaction with ma-trix proteins (Andreasen et al., 2003; Ferguson et al., 1991;
Mackay et al., 1992; Picker et al., 1990). To identify a mechanism
that may underlie ShK-186’s activity, we examined the pep-
tide’s effect on activated b1 integrin expression in Ova-specific
Tem cells. Activation of b1 integrin in T cells is calcium depen-
dent and is probably mediated by a concerted mechanism in-
volving the increase of intracellular calcium and activation of
PKC (Lim et al., 2000; Rowin et al., 1998). We have previously
shown that ShK-186 treatment suppresses antigen-induced
calcium signaling in Tem cells (Beeton et al., 2006). Therefore,
we hypothesized that ShK-186 treatment immobilized Tem cells
at the site of DTH by reducing intracellular calcium and thereby
inhibiting the activation of b1 integrin. To mimic the conditions of
the in vivo experiments, we incubated Ova-specific Tem cells
in vitro with antigen-pulsed irradiated thymocytes for 48 hr to
generate activated Tem effectors. In other experiments, Tem
cells were ‘‘rested’’ in IL2-containing medium for 6 days (resting
Tem cells). Intracellular calcium and activated b1 integrin ex-
pression were then measured in activated or resting Tem cells
exposed to 100 nM ShK-186 or vehicle for 30 min. As expected,
intracellular calcium was elevated in activated Tem effectors,
compared to resting Tem cells (Figure S5). Acute exposure to
ShK-186 significantly lowered intracellular calcium in activated
Tem cells (p < 106), but did not affect intracellular calcium in
resting Tem cells. We also measured activated b1 integrin ex-
pression by staining with the HUTS-21 mAb (Luque et al.,
1996) and gating on the GFP+ population. HUTS-21 staining
was detected on activated but not resting Tem cells (Figures
6I and 6J). ShK-186 reproducibly minimized HUTS-21 staining
in activated Tem cells to levels comparable to background
staining (p < 0.01), paralleling its inhibitory effect on intracellular
calcium. Confirming the calcium dependence of b1-integrin ac-
tivation, acute removal of external Ca2+ brought HUTS-21 ex-
pression to baseline (p < 0.01). Our results thus suggest that
ShK-186 immobilizes Tem cells at inflammatory sites by sup-
pressing calcium signaling and thereby preventing b1 integrin
activation.
Motility of CCR7+ T Cells in the LymphNode Is Unaltered
by ShK-186 Treatment
The finding that ShK-186 dramatically reduces motility of Tem
cells in ear tissue prompted us determine its effects on resting
T cells in lymph node. A pool of predominantly CD3+CCR7+ cells
(Figure 7A) was purified from secondary lymphoid organs, la-
beled with CFSE, and transferred into Lewis rats, which received
either ShK-186 or saline by subcutaneous injection at the time of
cell transfer. CFSE-labeled T cells in both groups (saline- or ShK-
186-treated rats) were highly motile, displaying no difference in
cell localization velocities, directional preference, or meander in-
dex within the lymph node (Figures 7B–7F;Movies S12 and S13).
Thus, ShK-186 does not affect the motility of lymph-node-
resident T cells.
Evaluation of ShK-186 in Other Disease Models
We evaluated the therapeutic effectiveness of ShK-186 in a rat
EAE model that closely follows the clinical course of human
MS. DA rats immunized with spinal cord homogenate and com-
plete Freund’s adjuvant developed relapsing-remitting EAE
about 10 days after immunization (Figure S6A). T cells in theImmunity 29, 602–614, October 17, 2008 ª2008 Elsevier Inc. 605
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Imaging DTH and Effects of Kv1.3 Channel BlockFigure 3. Activation and Motility of CCR7 Effector Cells at the Site of DTH
(A) GFP+ Ova-specific T cells (green) in subcutaneous ear tissue 3 hr after antigen injection interacting with local APCs (red) among collagen fibers (blue). Major
tick marks = 20 mm.
(B) Enlarged, highly motile CCR7 effector cells (green) 24 hr after antigen injection, imaged crawling along collagen-fiber bundles.
(C) Large, highly motile CCR7 effectors in the subcutaneous tissue 42 hr after antigen injection.
(D) Distributions of instantaneous velocities of CCR7 effector cells at 3 hr. Those in contact with an APC are shown by red bars (mean velocity 3.9 mm/min,
n = 1722 measurements); those in contact with collagen are shown by blue bars (5.3 mm/min, n = 758; p < 0.05).
(E) Corresponding velocity distributions of CCR7 effector cells 24 hr after antigen challenge. CCR7 effectors in contact with collagen fibers were highly motile
(blue bars, 11.1 mm/min, n = 1654), whereas those contacting antigen-bearing APCs showed lower velocities (red bars, 7.4 mm/min, n = 1568; p < 0.05).
(F) Velocity distributions of CCR7 effector cells contacting collagen (blue bars, 12.0 mm/min, n = 2213) or encountering an antigen-bearing APCs (red bars,
7.0 mm/min, n = 1359; p < 0.05) measured 42 hr after antigen challenge.606 Immunity 29, 602–614, October 17, 2008 ª2008 Elsevier Inc.
Immunity
Imaging DTH and Effects of Kv1.3 Channel Blockcentral nervous system (CNS) of ratswith EAEwere initially amix-
ture of CD4+CCR7+ naive and Tcm and CD4+CCR7 Tem cells
because of the adjuvant effect, but as the disease progressed,
the majority of T cells in the rat CNSwere CD4+CCR7 Tem cells
(Figure S6B) similar to T cells in the CNS in human MS patients
(Kivisakk et al., 2004; Rus et al., 2005). Daily subcutaneous ad-
ministration of ShK-186 from disease onset had no effect on
the initial phase of EAE, but produced a striking reduction in
the clinical score, coincident with the emergence of the Tem
population in the CNS (Figure 7G). Disease amelioration was ac-
companied by reduced demyelination and inflammatory infiltrate
in the CNS (Figure S6C and Table S1). The presence of inflam-
matory cells in the CNS of treated rats is consistent with the
two-photon DTH data, where Tem cells enter but are immobi-
lized in inflamed tissues in ShK-186-treated rats.
Although Kv1.3 blockers have been previously shown to have
a good safety profile in rats and monkeys (Beeton et al., 2006),
the primary concern in development of an autoimmune therapy
is whether it compromises the protective immune response.
We examined whether ShK-186, at the dose that suppresses
DTH and chronic EAE, would affect clearance of two medically
important infections: influenza and chlamydia. In addition, we
examined effects of another Kv1.3-selective blocker, PAP1
(Azam et al., 2007). As a control, we used dexamethasone, which
broadly suppresses the immune response. Vehicle-treated
Sprague Dawley rats cleared the influenza virus in 4 days, as
did rats treated with ShK-186 or PAP-1, whereas dexametha-
sone significantly delayed clearance (Figure 7H and
Figure S7A). In a parallel study, Lewis rats given saline or ShK-
186 cleared a chlamydial infection equally rapidly, whereas
rats treated with dexamethasone did not clear the infection dur-
ing the 4 weeks of observation (Figure 7I and Figure S7B).
DISCUSSION
Delayed-type hypersensitivity is an inflammatory immune re-
sponse initiated by the activation of CD4+ Tem cells, followed
by recruitment of macrophages and other effector cells (Szabo
et al., 2003). To image the cellular dynamics of this process,
we developed a method enabling in situ two-photon microscopy
in inflamed ear tissue. We provide the first visualization of Tem
cell motility and interaction with APCs and collagen structural el-
ements in peripheral tissue during a DTH immune response.
Moreover, we report that a specific blocker of the voltage-gated
Kv1.3 potassium channel (ShK-186) inhibits DTH and sup-
presses Tem effector cell activation in inflamed tissues, but
does not alter acute immune clearance in two infectious-disease
models.At the onset of DTH, cytokine cross-talk between tissue-
resident APCs and skin-homing T cells initiates an inflammatory
cascade. Three hours after antigen challenge, we find that Ova-
specific Tem cells are predominantly engaged in prolonged con-
tacts with tissue-resident APCs in the subcutaneous tissue and
display low overall motility. In contrast, antigen-irrelevant Tem
cells are highly motile in the inflamed tissue. This mirrors the be-
havior of myelin basic protein-specific Tem cells invading the
spinal cord, where many of the cells appeared tethered to a fixed
point (Kawakami et al., 2005). The Ova-specific Tem cells used
here were highly motile in spinal cord tissue, but became immo-
bilized after intrathecal injection of Ova, presumably because of
interaction with local APCs (Kawakami et al., 2005). Our results
extend those observations by showing that during the course
of an immune response, Tem effector cells arrest in contact
with APCs enlarge and become highly motile through dense net-
works of collagen. Although less numerous from 24 to 42 hr, the
Tem effector cells move rapidly, primarily tracking along bundles
with apparently random changes in direction at scaffold junc-
tions, but also occasionally traversing between bundles. Such
directionality contrasts with the random motility of these same
cells in spinal cord (Kawakami et al., 2005), and with the random
motion of CCR7+ cells in lymph node (Miller et al., 2002).
When Tem cells encounter cognate-antigen-bearing APCs in
the ear tissue, they enter an activation cascade that is mirrored
by changes in cell dynamics. As the cells activate, Ca2+ signaling
is initiated; motility is arrested; and the cells enlarge, produce cy-
tokines, and alter gene expression in preparation for cell prolifer-
ation. The enlarged T cell blasts later release from the APCs and
migrate rapidly along collagen fibers, while continuing to have
further encounters with APCs. In vitro studies have shown that
Ca2+ signaling is required for stable T cell-APC association and
alterations in gene expression (Negulescu et al., 1996, 1994). If
ShK-186 is present, Ca2+ signaling is attenuated, resulting in re-
duced activation of b1 integrin and suppression of cytokine pro-
duction and cell proliferation (Beeton et al., 2006). Consequently,
Tem cells do not reactivate at the site of DTH in rats treated with
ShK-186, as indicated by their failure to form productive con-
tacts with APCs or enlarge. The attenuated calcium signaling
and reduced activated b1 integrin expression probably contrib-
ute to the nonmotile state of the Tem cells. Integrins a1b1
(VLA-1) and a2b1 (VLA-2) enable lymphocytes to adhere to col-
lagen in inflamed tissue (de Fougerolles et al., 2000), and in this
study a1b1 and a4b1 (VLA-4) are both upregulated by Ova-spe-
cific GFP+ Tem cells that are found tracking along collagen in ear
tissue. Together, our results and those of others (reviewed in
Dustin and de Fougerolles [2001]) indicate that normal Ca2+ sig-
naling and maintenance of activated b1 integrin in Tem cells are(G) Mean velocities of CCR7 effector cells as a function of their cross-sectional areas at different times during DTH. Values were expressed as mean ± standard
error (SE).
(H) Percentages of time for which CCR7 effectors were in contact with local APCs or collagen fibers at 3 hr (APC: 69%, collagen: 31%), 24 hr (APC: 49%, col-
lagen: 51%), and 42 hr (APC: 38%, collagen: 62%) after antigen challenge. nR 50 cells.
(I) Duration of CCR7 effector T cell contacts with local APCs at varying times after antigen challenge; mean contact durations are represented by red bars at 3 hr
(24 min, n = 54 contacts in 6 experiments), 24 hr (7 min, n = 77 contacts in 3 experiments), and 42 hr (3.5 min, n = 55 contacts in 3 experiments).
(J) Bystander GFP+ Ova-specific T cells (green) among collagen fibers (blue) in subcutaneous ear tissue 24 hr after induction of active DTH by injection of hen-egg
lysozyme (HEL). Development of the DTH response was measured by ear swelling (44% increase in ear thickness, n = 2). Major tick marks = 20 mm.
(K) Velocity distribution of bystander GFP+ Ova-specific T cells (mean velocity 10.4 mm/min, n = 5222).
(L) Mean velocities of bystander GFP+Ova-specific T cells as a function of their cross-sectional area 24 hr after induction of active DTH. Valueswere expressed as
mean ± SE.Immunity 29, 602–614, October 17, 2008 ª2008 Elsevier Inc. 607
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Imaging DTH and Effects of Kv1.3 Channel BlockFigure 4. CCR7 Effector Cells Preferentially Crawl along Collagen Fibers
(A) Representative image of effector T cells in the collagen-rich subcutaneous tissue obtained 24 hr after antigen challenge. Left panel is a ‘‘top-view’’ compres-
sion through an image stack captured at a single time point; right panel overlays cell tracks recorded throughout a 4min imaging sequence, illustrating movement
of T cells along collagen fibers.
(B) Cell tracks plotted normalizing the orientation of adjacent collagen fibers along the x axis. The 3D plots of effector cell tracks demonstrate preferential motility
along the x axis (i.e., parallel to the collagen-fiber bundles).
(C) Meander index (displacement from origin/distance traveled) for effector cells in regions of long collagen fibers (0.75 after 10 min; n = 20 cells). By comparison,
the meander index over this period is typically 0.4 for random movement of naive T cells in a lymph node (cf. Figure 7F), and would be 1.0 for cells traveling in
a straight line. Values were expressed as mean ± SE.
(D) Cell tracks illustrating the circuitous paths at collagen-fiber junctions. Panels show compressions along the z (upper) and y (lower) axes: tracks are pseudo-
colored, representing time throughout a 36 min imaging record (purple = start; white = finish). Major tick marks are at 20 mm.
(E) Left panel shows examples of cells moving between adjacent collagen fibers (red and gold tracks) and a cell traversing local collagen structures (turquoise
track), depicted in various orientations. Right panel shows 3D plots of these same tracks after normalization of their starting points, and with the turquoise track
reoriented to the opposite axis for better visualization.necessary for Tem cell activation and subsequent motility in the
collagen-rich tissue environment.
Altered motility and suppression of Ca2+ signaling provide
a plausible mechanism for the selectivity and effectiveness of
Kv1.3 blockers in preventing or treating disease in five distinct
autoimmune models that are mediated by Tem cells: EAE in
Lewis rats induced by adoptively transferred myelin-specific
Tem cells (MS model) (Beeton et al., 2005; Beeton et al., 2001),
chronic relapsing-remitting EAE in DA rats (MS model)608 Immunity 29, 602–614, October 17, 2008 ª2008 Elsevier Inc.(Figure 7G), pristane-induced arthritis in DA rats (RA model)
(Beeton et al., 2006), experimental autoimmune diabetes melli-
tus in BB rats (T1DM model) (Beeton et al., 2006), and allergic
contact dermatitis (Azam et al., 2007). Kv1.3 channel blockade
during treatment of an autoimmune or inflammatory condition
would reduce the ability of T cells to locate APCs in the tissue en-
vironment and Ca2+ signaling and downstream activation re-
sponses by T cells that do make contact with APCs. Currently
available immunosuppressive agents, including natalizumab
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y ShK-186
) Dose-dependent inhibition of Kv1.3 currents in Ova-specific GFP+ CCR7
ffectors by ShK-186. Kd = 65 ± 5 pM; n = 3 cells. Inset shows representative
v1.3 current traces in the absence or presence of 10 pM or 100 pM ShK-186.
) Dose-dependent inhibition of CCR7 T cell proliferation by ShK-186. IC50 =
80 ± 37 pM; n = 3 experiments.
) Suppression of DTH-induced ear swelling by administration of 100 mg/kg
hK-186 at the time of antigen challenge and 24 hr after antigen challenge
lled bars), relative to saline-treated rats (open bars). ** p < 0.01; *** p < 0.05.(Tysabri), a VLA4 antagonist that prevents effectors from enter-
ing tissues (Li et al., 2006), and S1P1-receptor-antagonists
(e.g., FTY720) that regulate lymphocyte trafficking at vascular
endothelial and lymphatic endothelial barriers (Rosen et al.,
2007), are less selective for Tem cells.
The Kv1.3 channel in Tem cells is an important molecular tar-
get in inflammatory and autoimmune disorders. Tem cells are im-
plicated in the pathogenesis ofMS, and therapies that selectively
target Tem cells, while sparing naive and Tcm cells, may have
utility in MS therapy (Beeton et al., 2006; Haegele et al., 2007;
Hu et al., 2007; Kivisakk et al., 2004; Krakauer et al., 2006; Rus
et al., 2005; Wulff et al., 2003a). The normal timeline to clearance
of influenza virus and Chlamydia trachomatis in rats treated with
a DTH-suppressing dose of ShK-186 is probably the result of re-
dundancy in the multiple types of immune cells and cellular
mechanisms involved in the clearance of these infectious
agents. Preferential suppression of Tem cells in psoriasis pa-
tients by Alefacept (Ellis and Krueger, 2001) does not enhance
the frequency of infections, and patients receiving Alefacept
mount adequate vaccine antibody responses (Goffe et al.,
2005; Gottlieb et al., 2003). In addition, Kv1.3 blockers are not
expected to compromise anti-tumor immune responses (Kle-
banoff et al., 2005), or responses to chronic infections (Heydt-
mann et al., 2006; Stubbe et al., 2006), which aremore effectively
mediated by Tcm cells than by Tem cells.
In summary, our two-photon imagingmethodology reveals the
Tem cell dynamics underlying the normal immune response in
peripheral tissues and provides mechanistic insights into the
therapeutic potential of immunosuppression by targeting the
Kv1.3 channels on Tem cells. The profound effects of Kv1.3
blockers on the motility and activation of Tem cells at the tissue
site of antigen challenge suggest a promising strategy for treat-
ment of chronic autoimmune diseases mediated by autoreactive
Tem cells, a therapy based upon prolonged immobilization of
Tem effectors at sites of inflammation and by preventing
effectors from making contact with APCs and receiving activa-
tion signals.
EXPERIMENTAL PROCEDURES
Animals
Female inbred Lewis and DA rats were purchased from Harlan-Sprague Daw-
ley (Indianapolis, IN, USA), and female inbred Sprague Dawley rats were pur-
chased from Charles River (Raleigh, NC, USA). Animals were housed under
clean conditions with irradiated rodent chow and acidified water ad libitum.
All procedures were in accordance with National Institutes of Health (NIH)
guidelines and approved by the University of California, Irvine, Institutional An-
imal Care and Use Committee.
Cells
Lewis ratOva-specificCD4+Tcells transducedwithGFP (Flugeletal.,1999)were
maintained in culture by alternating phases of expansion in medium containing
T cell growth factor (TCGF) and phases of stimulationwithOva (Sigma, St. Louis,
MO, USA) in the presence of irradiated thymocytes as antigen-presenting cells,
(D) Recovery of Ova-specific GFP+ CCR7 effectors from whole ear tissue
from saline-treated (open bars) and ShK-186-treated animals (filled bars).
Rats were extensively cardiac perfused with saline to remove cells from blood
vessels before the ears were explanted and analyzed for GFP+ cells (n = 5 rats).
Values were expressed as mean ± standard deviation (SD).Immunity 29, 602–614, October 17, 2008 ª2008 Elsevier Inc. 609
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Motility and Activation by ShK-186
(A–C) Maximum-intensity projections of two-pho-
ton image stacks acquired in the subcutaneous
ear tissue at 3, 24, and 42 hr after antigen chal-
lenge and treatment with ShK-186. Ova-specific
GFP+ CCR7 effector cells (green), collagen-fiber
bundles (blue), and APCs bearing Ova-TR (red)
are shown. Major tick marks = 20 mm.
(D–F) Distributions of instantaneous velocities of
CCR7 effectors cells in ShK-186-treated animals
at corresponding time points after Ova-TR chal-
lenge. Arrows mark mean velocities (3 hr: 2.7 ±
0.04 mm/min, n = 2397 measurements; 24 hr: 2.1
± 0.05 mm/min, n = 2870; 42 hr: 1.2 ± 0.04 mm/
min, n = 2227).
(G) Percentage of time effector cells contacted
APCs (red bars) or collagen (blue bars) at different
time points after Ova-TR challenge (n = 34–46 cells
in 3 or 4 experiments).
(H) Sizes (cross-sectional area) of CCR7 effector
cells in saline-treated (open symbols) and in ShK-
186-treated animals (filled symbols) at different
times after Ova-TR challenge. Mean values are in-
dicated by red bars (in saline-treated animals at 3,
24, and 42 hr after antigen challenge, respectively,
130 ± 9.6, 280 ± 11.0 mm2, and 289 ± 11.6 mm2; in
ShK-186-treated animals, 32 ± 2.5, 38 ± 4.1, and
44 ± 4.mm2).
(I) FACS plots of activated b1 integrin (exposed
amino acids 355–425) on the surface of activated
Tem cells with and without ShK treatment. Acti-
vated Tem cells have the activated form of b1 in-
tegrin on the cell surface (gray solid line), which is
suppressed by 100 nM ShK-186 (black solid line)
to levels similar to control staining (twooverlapping
dotted lines, left panel).
(J)Mean fluorescence intensity (MFI) ratios (HUTS-
21 staining/secondary control) for activated Tem
cells (1.8 ±0.08SE, n=21)were significantly higher
(p < 0.01) than in activated Tem incubated in 0Ca2+
solution (1.1 ± 0.07 SE, n = 12) or treated with
100 nM ShK (1.06 ± 0.03 SE, n = 17). Resting
Tem cells (day 6) had low levels of activated b1 in-
tegrin thatwere not significantly different (pR0.44)
than in control conditions (2 mM Ca2+;1.2 ± 0.04,
SE, n = 4), 0 Ca2+ (1.2 ± 0.05, n = 4), or with ShK
treatment (1.3 ± 0.12, n = 4).as described (Beeton et al., 2001). See Supplemental Experimental Procedures
for additional details. T cells were isolated from Lewis rat spleens and lymph
nodes with a MACS separation column (Miltenyi Biotec, Auburn, CA, USA). Pu-
rities of CD3+ and of CD4+ T cells were >95%, as indicated by flow cytometry.
Potassium-Channel Blockers
ShK-186 was synthesized as described (Beeton et al., 2005). PAP-1 (Schmitz
et al., 2005) was a kind gift from H. Wulff (UC Davis, CA).
Delayed-Type Hypersensitivity and Administration of ShK-186
Adoptive DTH was induced in 7- to 9-week-old Lewis rats by the intraperito-
neal transfer of 10 3 106 GFP+ Ova-activated effector T cells (Beeton and
Chandy, 2007). Rats were challenged 48 hr later with 20 mgOva-TR in the pinna
of the right ear and saline in the pinna of the left ear. Rats received subcutane-
ous injections in the scruff of the neck of ShK-186 (100 mg/kg/day) or vehicle
(PBS + 2% Lewis rat serum) at the time of challenge and 24 hr later. Induction610 Immunity 29, 602–614, October 17, 2008 ª2008 Elsevier Inc.of active DTH with the nonrelevant antigen HEL was initiated by priming 7- to
9-week-old Lewis rats with an intradermal injection of emulsion of HEL
(100 mg/rat) in complete Freund’s adjuvant (Difco, Detroit, MI, USA). Five
days later, 10million activated Ova-GFP T cells were injected intraperitoneally.
Two days later, the rats were challenged with an injection of HEL dissolved in
saline in the pinna of one ear (20 mg/20 ml) and saline in the other ear. Ear thick-
ness was measured at the site of injection 3, 24, and 42 hr after challenge with
a spring-loaded micrometer (Mitutoyo, Spokane, WA, USA) and the difference
in ear Ova-TR versus saline-challenged ears was calculated. Statistical analy-
sis was carried out with the Mann-Whitney U test.
Tissue Preparation
DTH in rat ears is characterized by effector T cell infiltration of the subcutane-
ous tissue and dermis (Hancock et al., 1994). After determining that autofluor-
escence and second-harmonic signals from hair follicles obscured visualiza-
tion of inflammatory cells and antigen-bearing APCs, we developed
Immunity
Imaging DTH and Effects of Kv1.3 Channel BlockFigure 7. CCR7+ T Cell Motility in the Lymph Node and Evaluation of Three Disease Models
(A) Adoptively transferred CD3+ T cells are CCR7+. Solid line = CCR7 staining; dotted line = background staining. The tissue-weight-normalized number of cells
recovered from lymph nodes of saline- and ShK-186-treated animals did not differ, indicating no effect of ShK-186 treatment on homing to lymph node (data not
shown, n = 2 for each condition).
(B and C) Images show maximum-intensity projection ‘‘snapshots’’ of CD3+ CCR7+ T cells in an inguinal lymph node 3 hr after treatment with saline or ShK-186
(100 mg/kg), respectively. Pseudocolored cell tracks depict T cell movements over 6 min.
(D) Representative 3D displacement plots of T cells in saline-treated (top) and ShK-186-treated lymph nodes (bottom) after normalizing starting coordinates.
(E) Distributions of instantaneous velocities of saline-treated (white) and ShK-186-treated (black) CD3+ CCR7+ T cells. Mean values (16.6 and 16.2 mm/min, re-
spectively) are not statistically different.
(F) Meander index (displacement from origin/distance traveled) as a function of time for CCR7+ T cells in lymph nodes from saline-treated (open circles) and ShK-
186-treated animals (closed circles).
(G) Effect of ShK-186 on the course of CR-EAE. White, saline subcutaneous injection, n = 14 rats; black, ShK-186 100 mg/kg/day subcutaneous injection, n = 15
rats.
(H) Lack of effects of ShK-186 and PAP-1 on clearance of rat-adapted influenza virus. White, peanut oil orally, n = 5; red, PAP-1 50 mg/kg/day orally; black, ShK-
186 100 mg/kg/day subcutaneous injection, n = 5 rats; gray, dexamethasone 2 mg/kg/day orally, n = 5. * p < 0.05, **** p < 0.01.
(I) Lack of effects of ShK-186 on clearance of Chlamydia trachomatis. White, saline subcutaneous injection, n = 10; black, ShK-186 100 mg/kg/day subcutaneous
injection, n = 10; gray, dexamethasone 2 mg/kg/day subcutaneous injection, n = 4.
Values were expressed as mean ± SD.a method to expose the subcutaneous tissue of the ear for imaging during
DTH. Lewis rats with DTH were euthanized 3, 24, or 42 hr after challenge,
and after cardiac perfusion, the ears were removed by a single angled slice
and kept in C02-independent media on ice. Under a 103 dissecting micro-
scope, edges of the ear (2 mm of tissue on each side) were removed to aid
in separation of the epidermis and dermis together with the hair follicles. Tissue
separation began at the proximal end of the ear with iridectomy dissection
scissors (3 mm Vannas style, Fine Science Tools, Foster City, CA, USA)
used to cut small extensions of connective tissue between the two layers.
The preparation was then immediately mounted under the two-photon micro-scope, with the exposed subcutaneous tissue on the dorsal side of the ear fac-
ing the objective lens. Subsequent hemotoxylin and eosin staining of sections
from imaged tissue confirmed tissue integrity.
Footpad DTH and Intravital Imaging
Adoptive DTH in the footpad of 7- to 9-week-old Lewis rats was induced by the
intraperitoneal transfer of 10 3 106 GFP+ Ova-activated effector T cells
(Beeton and Chandy, 2007), followed by antigen challenge 48 hr later with
20 mg Ova-TR in the right front paw. Twenty-four hours after antigen challenge,
animals were anesthetized with 100 mg/kg ketamine, 10 mg/kg xylene, andImmunity 29, 602–614, October 17, 2008 ª2008 Elsevier Inc. 611
Immunity
Imaging DTH and Effects of Kv1.3 Channel Block1/2 dosages were given every 45 min after initial anesthesia dose. The imaged
paw was immobilized in a liquid-tight chamber filled with prewarmed RPMI for
two-photon imaging of the ventral surface. DTH reactionwas assessed by paw
swelling and visualization of inflamed tissue marked by redness and observa-
tion of animal preference for the alternate forepaw.
Two-Photon Imaging and Data Analysis
Two-photon imaging was performed as described previously (Matheu et al.,
2007; Miller et al., 2002), with an upright Olympus BX50 microscope fitted
with a 203 water-immersion objective (numerical aperture 0.95), a Spectra-
Physics Tsunami femto-second laser, a resonant-mirror scan head, and a mo-
torized focus controller (Prior Scientific, Rockland, MA, USA) (Nguyen et al.,
2001). Images were acquired under software control by METAMORPH (Uni-
versal Imaging, Downingtown, PA, USA). Three-dimensional (3D) image stacks
in ear tissue (x, y, z) were acquired at 18 s time intervals through an imaging
volume 50 mm deep. Images and movies were processed with the 3D analysis
software IMARIS 5.5.3., 64-bit version (Bitplane AG, Saint Paul, MN, USA).
Three-dimensional graphs were prepared with ED Grapher (RomanLab Soft-
ware, Vancouver, British Columbia, Canada). An excitation wavelength of
890 gave optimal second-harmonic generation from collagen together with
two-photon excitation of GFT and TR, and these signals were imaged with
three photomultiplier channels (respectively, blue, green, and red) in conjunc-
tion with 500 nm and 560 nm dichroic mirrors and a 510 nm long-pass filter.
Cell size was measured as cross-sectional (x-y) area, with an ellipsoid shape
approximation. Data are presented as mean ± 1 standard error of the mean
(SEM). Tests of statistical significance were performed with a two-tailed Stu-
dent’s t test, or Mann-Whitney U test where indicated. Significance is denoted
in figures as * = 0.05; ** = 0.01; *** = 0.001; **** = 0.0001.
T Cell Motility in the Lymph Node
CD3+ T cells were purified from Lewis rat spleen and lymph nodes (Miltenyi
Biotech cell-separation kit: 130-090-320), labeled with 4 mm carboxyfluores-
cein diacetate succinimidyl ester (CFSE, Invitrogen) for 30 min and adoptively
transferred by tail-vein injection. Concurrent with adoptive transfer, animals re-
ceived a subcutaneous injection of either saline or ShK-186 (100 mg/kg). Ani-
mals were euthanized 3 hr after adoptive transfer and treatment. Inguinal,
axillary, and cervical lymph nodeswere removed and imaged as previously de-
scribed (Miller et al., 2002). T cell recovery from lymph nodewas determined as
percent recovered, normalized by total weight of lymph node tissue.
Homing of Ova T Cells to the Ears
For measurement of homing of the Ova-specific CCR7 effector T cells to the
ears of Lewis rats with DTH, animals were euthanized 3, 24, or 42 hr after chal-
lenge. Ears were removed after cardiac perfusion with saline. Single-cell sus-
pensions were prepared and analyzed for the presence of GFP+ cells on a BD
FACSCalibur with CellQuest software (BD Biosciences, San Jose, CA, USA).
Electrophysiology
Ova-T cells were patch-clamped in the whole-cell configuration at rest and
48 hr after activation with Ova as described (Wulff et al., 2003b). See Supple-
mental Experimental Procedures for additional details.
Calcium Imaging
Ratiometric calcium imaging was performedwith Tem cells loaded with Fura-2
as described (Fanger et al., 2001), with cell-based calibration using ionomycin
and EGTA or 10 mM external Ca2+ to achieve Rmin and Rmax, respectively.
In Vitro Assessment of Activated b1 Integrin
In the adoptive DTH model, Ova-specific Tem cells were activated in vitro for
48 hr before adoptive transfer into rats. Therefore, for the HUTS staining exper-
iment, we activated the cells in vitro for 48 hr before assessing the effect of
ShK-186 on HUTS expression. Cells were stained with monocolonal HUTS-
21 (BD Biosciences), which recognizes an epitope among amino acids 355–
425 that is exposed upon activation of b1 integrin (Luque et al., 1996). FACS
analysis of HUTS-21 staining was performed by gating on the GFP+ cell pop-
ulation. The observed shift in mean fluorescence ratio of activated cells is con-
sistent with previous studies (Gomez et al., 1997; Levite et al., 2000; Luque
et al., 1996). See Supplemental Experimental Procedures for additional details.612 Immunity 29, 602–614, October 17, 2008 ª2008 Elsevier Inc.Proliferation Assays
Effect of ShK-186 on the proliferation of Ova GFP+ Tem cells was determined
with [3H]-thymidine incorporation assays as described (Beeton et al., 2005;
Beeton et al., 2001). See Supplemental Experimental Procedures for additional
details.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, one ta-
ble, seven figures, and thirteen movies and can be found with this article online
at http://www.immunity.com/cgi/content/full/29/4/602/DC1/.
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